- Home
- TRI vs TEVA Comparison
TRI vs TEVA Comparison
Compare TRI & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRI | TEVA |
|---|---|---|
| Founded | 1851 | 1901 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4B | 40.5B |
| IPO Year | 2002 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TRI | TEVA |
|---|---|---|
| Price | $97.64 | $36.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $154.58 | $38.63 |
| AVG Volume (30 Days) | 1.5M | ★ 4.4M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | N/A | ★ 183.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.90 | N/A |
| Revenue Next Year | $7.89 | $2.97 |
| P/E Ratio | $25.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $76.28 | $18.21 |
| 52 Week High | $173.39 | $38.37 |
Technical Indicators
Market Signals| Indicator | TRI | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 41.71 | 50.21 |
| Support Level | $79.70 | $30.42 |
| Resistance Level | $100.66 | $37.17 |
| Average True Range (ATR) | 3.60 | 1.03 |
| MACD | -1.52 | -0.22 |
| Stochastic Oscillator | 0.36 | 25.93 |
Price Performance
Historical ComparisonAbout TRI Thomson Reuters Corp
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.